β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ’ Press Releases
| Date | Press release |
|---|---|
| 2026-06-04 16:15:00 | Royalty Pharma To Present At The Goldman Sachs 47th Annual Global Healthcare Conference New york, june 04, 2026 (globe newswire) -- royalty pharma plc (nasdaq: rprx) today announced that it will participate in a fireside chat at the goldman sachs 47th annual global healthcare conference on tuesday, june 9, 2026 at 4:00 p.m. et. |
| 2026-05-07 16:15:00 | Royalty Pharma To Present At Upcoming Investor Conferences New york, may 07, 2026 (globe newswire) -- royalty pharma plc (nasdaq: rprx) today announced that it will participate in the following upcoming investor conferences during the month of may: |
| 2026-05-06 07:00:00 | Royalty Pharma Reports First Quarter 2026 Results Portfolio receipts growth of 10% to $925 million; royalty receipts growth of 13% net cash provided by operating activities of $718 million raised full year 2026 guidance: portfolio receipts expected to be $3,325 million to $3,450 million new york, may 06, 2026 (globe newswire) -- royalty pharma plc (nasdaq: rprx) today reported financial results for the first quarter of 2026 and raised full year 2026 guidance for portfolio receipts. βroyalty pharma has delivered a strong start to 2026 across multiple dimensions. |
| 2026-04-21 13:00:00 | Royalty Pharma Launches Global Translational Prize To Recognize Breakthrough Scientific Innovation New york, april 21, 2026 (globe newswire) -- royalty pharma plc (nasdaq: rprx) today announced the launch of the royalty pharma translational prize, which recognizes exceptional achievements in translational medicine. the prize will honor scientific breakthroughs that bridge the gap between fundamental discovery and the development of new medicines that improve and extend patientsβ lives. it will include a $1 million award distributed among one or more established scientists whose work has translated unique scientific insights into medicines with significant impact, particularly contributions not yet recognized by the fieldβs most prominent awards. |
| 2026-04-17 08:30:00 | Royalty Pharma Declares Second Quarter 2026 Dividend New york, april 17, 2026 (globe newswire) -- the board of directors of royalty pharma plc (nasdaq: rprx) has approved the payment of a dividend for the second quarter of 2026 of $0.235 per class a ordinary share. |
| 2026-04-15 16:15:00 |
|
| 2026-03-30 07:15:00 |
|
| 2026-03-23 07:15:00 |
|
| 2026-03-17 16:01:00 |
|
| 2026-03-02 07:00:00 |
|
| 2026-03-02 06:10:00 |
|
| 2026-02-26 16:15:00 |
|
| 2026-02-11 07:00:00 |
|
| 2026-01-20 16:15:00 |
|
| 2026-01-12 07:15:00 |
|
π° Browse additional press releases for Royalty Pharma!
Sign up for free or log inπ Join us and grab your copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks"